Long-term mortality in patients with germ cell tumors: Effect of primary cancer site on cause of death

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 26.e9-26.e15

  Alanee, Shaheen R ^a   Feldman, Darren R ^a   Russo, Paul ^a,b   Konety, Badrinath ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Extragonadal primary; Germ cell tumor; Mediastinum; Risk assessment

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AORTA ANEURYSM; AORTA DISSECTION; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; DATA BASE; GERM CELL TUMOR; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HYPERTENSION; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; MYELOMA; NON SEMINOMATOUS GERMINOMA; NONHODGKIN LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SEMINOMA; SOLID TUMOR; AGED; CANCER REGISTRY; HEMATOLOGIC DISEASE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK ASSESSMENT; SEER PROGRAM; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84890797897     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.09.003     Document Type: Article

References (23)

1. Sheinfeld J., Herr H.W. Role of surgery in management of germ cell tumor. Semin Oncol 1998, 25:203-209.
2. Fossa S.D., Aass N., Harvei S., Tretli S. Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Br J Cancer 2004, 90:607-612.
3. Kollmannsberger C., Beyer J., Droz J.P., et al. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol 1998, 16:3386-3391.
4. Travis L.B., Fossa S.D., Schonfeld S.J., et al. Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005, 97:1354-1365.
5. Hainsworth J.D., Greco F.A. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol 1992, 19:119-127.
6. NCI. Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2011, based on the November 2010 submission; 2011. http://www.seer.cancer.gov.
7. Fritz A., Percy C., Jack A., et al. International classification of diseases for oncology 2000, World Health Organization, Geneva, Switzerland. 3rd ed.
8. Hart W.R. Primary endodermal sinus (yolk sac) tumor of the liver. First reported case. Cancer 1975, 35:1453-1458.
9. Johnson D.E., Laneri J.P., Mountain C.F., Luna M. Extragonadal germ cell tumors. Surgery 1973, 73:85-90.
10. Mead G.M., Stenning S.P. The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol (R Coll Radiol) 1997, 9:207-209.
11. Hainsworth J.D., Einhorn L.H., Williams S.D., Stewart M., Greco F.A. Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy. Ann Intern Med 1982, 97:7-11.
12. Josefsen D., Ous S., Hoie J., Stenwig A.E., Fossa S.D. Salvage treatment in male patients with germ cell tumours. Br J Cancer 1993, 67:568-572.
13. Haugnes H.S., Wethal T., Aass N., et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol 2010, 28:4649-4657.
14. Cierniak A., Papiez M., Kapiszewska M. Modulatory effect of quercetin on DNA damage, induced by etoposide in bone marrow cells and on changes in the activity of antioxidant enzymes in rats. Rocz Akad Med Bialymst 2004, 49(Suppl 1):167-169.
15. Boos G., Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol Lett 2000, 116:7-16.
16. Choudhury R.C., Palo A.K., Sahu P. Cytogenetic risk assessment of etoposide from mouse bone marrow. J Appl Toxicol 2004, 24:115-122.
17. Bueno C., Catalina P., Melen G.J., et al. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 2009, 30:1628-1637.
18. Huddart R.A., Norman A., Shahidi M., et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003, 21:1513-1523.
19. Vaughn D.J., Palmer S.C., Carver J.R., Jacobs L.A., Mohler E.R. Cardiovascular risk in long-term survivors of testicular cancer. Cancer 2008, 112:1949-1953.
20. Hartmann J.T., Nichols C.R., Droz J.P., et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 2000, 92:54-61.
21. Feldman D.R., Bosl G.J., Sheinfeld J., Motzer R.J. Medical treatment of advanced testicular cancer. J Am Med Assoc 2008, 299:672-684.
22. Moyer L.A., Boyle C.A., Pollock D.A. Validity of death certificates for injury-related causes of death. Am J Epidemiol 1989, 130:1024-1032.
23. Scholz M., Zehender M., Thalmann G.N., Borner M., Thoni H., Studer U.E. Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol 2002, 13:121-124.